(Q53736162)

English

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. (English)

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

0 references

Hormone Replacement Therapy

1 reference

based on heuristic

inferred from title

author name string

Cem Dane

1

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

Banu Dane

2

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

Ahmet Cetin

3

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

Murat Erginbas

4

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

publication date

1 July 2007

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

Gynecological Endocrinology

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

23

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

7

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

398-403

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Low-dose hormone replacement therapy: effects on bone

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Benefits and risks of long-term low-dose oral continuous combined hormone therapy.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Raloxifene versus continuous combined estrogen/progestin therapy: densitometric and biochemical effects in healthy postmenopausal Taiwanese women

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Breast cancer and hormone-replacement therapy: the Million Women Study

1 reference

https://api.crossref.org/works/10.1080%2F09513590701414907

21 January 2018

Identifiers

10.1080/09513590701414907

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/17701771

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53736162&oldid=1502427075"